# e+ Oncologics Louisiana, L.L.C. – FDA Inspection, Mar 28, 2022

Source: https://www.keypedia.com/records/fda_inspections/e-oncologics-louisiana-llc/e2c5bdae-ef32-4608-a312-bdcb1f222b44
Source feed: FDA_Inspections

> FDA inspection 1171283 of e+ Oncologics Louisiana, L.L.C., March 28, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171283
- Company Name: e+ Oncologics Louisiana, L.L.C.
- Inspection Date: 2022-03-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1244909 - 2024-07-09
- FDA Inspection 1044991 - 2018-01-18
- FDA Inspection 945916 - 2015-10-21
- FDA Inspection 878411 - 2014-05-13
- FDA Inspection 793769 - 2012-07-26

Company: https://www.keypedia.com/companies/e-oncologics-louisiana-llc/ebf8bd7e-df16-4970-85c1-4603e143703f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d